GlaxoSmithKline Plc plans to raise its stake in its Indian consumer products arm GlaxoSmithKline Consumer Healthcare Ltd to 75 percent from 43.16 percent through an open offer, the manager to the offer said on Monday.
GlaxoSmithKline Plc along with its units will buy up to 13.39 million shares, or 31.84 percent in GlaxoSmithKline Consumer Healthcare, at 3,900 rupees per share, said HSBC Securities, the manager to the offer, in a statement.
As per Indian regulations, promoters of stock exchange-listed companies can hold up to a maximum of 75 percent stake. If the promoter shareholding rises beyond 75 percent, then the company has to be de-listed from the bourses.
(Reporting by Kaustubh Kulkarni; Editing by Gopakumar Warrier)
Trending On Reuters
California scientists are testing whether the illegal psychoactive drug commonly known as Ecstasy could help alleviate anxiety for terminally ill patients, the trial's principal funder said on Tuesday. Full Article
Japan nuclear regulator finishes review on Kyushu reactors, could be first to restart. Full Article
Factbox - China's leaders sign $80 bln of deals with India, Brazil and others. Full Article
Obama administration asks U.S. top court to decline Google copyright appeal. Full Article
Iraq Shi'ite militia take lead in campaign to reverse Islamic State gains Full Article